GO:0019395 fatty acid oxidation: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019395 fatty acid oxidation describes the removal of electrons from fatty acids by an electron-accepting substance, oxygen addition, or hydrogen removal, as defined by QuickGO.
• This process is central to energy homeostasis and is tightly linked to ethanol metabolism in the liver, where both pathways share redox and acetyl-CoA intermediates.
• Myoglobin can inhibit fatty acid oxidation in breast cancer cells via heme-dependent oxidant production, revealing a non-canonical regulatory mechanism.
• Copper availability modulates mitochondrial hydrogen peroxide emission during fatty acid oxidation, linking trace metal status to oxidative stress.
• Nutritional interventions such as royal jelly plus coenzyme Q10 and omega-3 supplementation can alter systemic markers of oxidative stress and muscle bioenergetics [4,6].
• Oxidized fatty acid products are detectable in human atherosclerotic plaque and in LDL from hyperlipidemic smokers, connecting fatty acid oxidation to cardiovascular pathology [7,8].
Description
Fatty acid oxidation (GO:0019395) is a fundamental biological process defined by the removal of one or more electrons from a fatty acid, with or without concomitant proton removal, by reaction with an electron-accepting substance, by addition of oxygen, or by removal of hydrogen. This process encompasses both enzymatic and non-enzymatic oxidation events and is distinct from the complete catabolic breakdown of fatty acids, although it is often studied in the context of mitochondrial beta-oxidation and peroxisomal oxidation. Researchers investigate fatty acid oxidation because it sits at the intersection of energy metabolism, redox biology, and disease pathogenesis [1,2]. In the liver, fatty acid oxidation interacts directly with ethanol metabolism, influencing NADH/NAD+ ratios and acetyl-CoA pools. In cancer, myoglobin can suppress fatty acid oxidation in breast cancer cells through heme-dependent oxidant production, independent of fatty acid binding. These findings highlight that fatty acid oxidation is not a single linear pathway but a network of reactions with cell-type-specific regulators and consequences.
fatty acid oxidation At A Glance
| GO ID | GO:0019395 |
|---|---|
| GO term | fatty acid oxidation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Removal of electrons from fatty acids via electron acceptors, oxygen addition, or hydrogen removal |
| Related pathways | Mitochondrial beta-oxidation, peroxisomal oxidation, lipid peroxidation, ethanol metabolism |
| Cellular locations | Mitochondria, peroxisomes, cytoplasm, extracellular space |
| Key cofactors | NAD+, FAD, coenzyme Q10, oxygen, heme iron |
| Disease relevance | Cardiovascular disease, cancer metabolism, oxidative stress, metabolic liver disease |
What Is GO:0019395?
According to the Gene Ontology, GO:0019395 fatty acid oxidation is the removal of one or more electrons from a fatty acid, with or without the concomitant removal of a proton or protons, by reaction with an electron-accepting substance, by addition of oxygen, or by removal of hydrogen. In practical terms, this definition covers enzymatic dehydrogenation steps in beta-oxidation, peroxisomal oxidation, and non-enzymatic lipid peroxidation events that generate oxidized fatty acid species. It does not describe the entire catabolic conversion of fatty acids to acetyl-CoA, but rather the oxidative chemical transformations that define the redox chemistry of fatty acids.
Why Is fatty acid oxidation Important in Cell Biology?
Fatty acid oxidation is essential for cellular energy production, redox balance, and membrane lipid quality control. Its dysregulation contributes to metabolic liver disease, atherosclerosis, cancer progression, and exercise-induced oxidative stress. Because the process generates reactive oxygen species and oxidized lipid products, it is a focal point for understanding how cells manage oxidative damage and how nutritional or pharmacological interventions can modulate disease risk [1,3,4,6,7,8].
• Provides a major source of ATP and acetyl-CoA during fasting and prolonged exercise.
• Interacts with ethanol metabolism in the liver, affecting redox state and steatosis.
• Modulates breast cancer cell migration through myoglobin-dependent oxidant production.
• Copper status influences mitochondrial H2O2 emission during fatty acid oxidation.
• Nutritional supplements such as royal jelly plus coenzyme Q10 can alter oxidative stress biomarkers after exercise.
• Omega-3 fatty acid intake influences skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults.
• Oxidized LDL from hyperlipidemic smokers contains fatty acid oxidation products.
• Unique fatty acid oxidation products are present in human atherosclerotic plaque.
• Serves as a target for understanding ferroptosis and lipid peroxidation in disease [2,8].
• Links trace metal homeostasis to mitochondrial reactive oxygen species emission.
What Happens During fatty acid oxidation?
Electron removal and redox chemistry
In simple terms: Fatty acids lose electrons to electron acceptors, which is the core chemical event of this GO term.
The defining event of GO:0019395 is the removal of one or more electrons from a fatty acid, either with or without proton removal, by reaction with an electron-accepting substance, by addition of oxygen, or by removal of hydrogen. In mitochondrial beta-oxidation, acyl-CoA dehydrogenases transfer electrons to FAD, which then feeds electrons into the electron transport chain via electron-transferring flavoprotein. This redox chemistry is sensitive to the local availability of electron acceptors such as NAD+ and coenzyme Q10, and it can be modulated by trace metals like copper that influence mitochondrial hydrogen peroxide emission during fatty acid oxidation. In the liver, the redox state is further complicated by ethanol metabolism, which alters NADH/NAD+ ratios and thereby affects fatty acid oxidation flux.
Mitochondrial and peroxisomal oxidation
In simple terms: Fatty acids are oxidized in mitochondria and peroxisomes through enzymatic steps that remove electrons and shorten the acyl chain.
Mitochondrial beta-oxidation is the canonical pathway for fatty acid oxidation, where acyl-CoA esters undergo cycles of dehydrogenation, hydration, and thiolysis to generate acetyl-CoA and reducing equivalents. Peroxisomal oxidation handles very-long-chain fatty acids and branched-chain fatty acids, transferring electrons directly to oxygen to produce hydrogen peroxide. Both organelles contribute to the overall flux of GO:0019395, and their relative activities can shift depending on substrate availability and cellular energy status. In skeletal muscle, omega-3 fatty acid supplementation has been shown to influence mitochondrial bioenergetics in older adults, suggesting that dietary fatty acid composition can modulate oxidative capacity.
Non-enzymatic lipid peroxidation
In simple terms: Fatty acids can also be oxidized without enzymes, especially when reactive oxygen species attack double bonds in polyunsaturated fatty acids.
Non-enzymatic fatty acid oxidation occurs when reactive oxygen species abstract hydrogen from polyunsaturated fatty acids, initiating a chain reaction that produces lipid hydroperoxides and reactive aldehydes. This chemistry is relevant to atherosclerosis, where unique fatty acid oxidation products have been identified in human plaque. Similarly, LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants shows evidence of peroxidation, indicating that dietary and environmental factors influence non-enzymatic fatty acid oxidation. Myoglobin can promote heme-dependent oxidant production that inhibits fatty acid oxidation in breast cancer cells, further illustrating the interplay between heme chemistry and lipid oxidation.
Integration with cellular metabolism
In simple terms: Fatty acid oxidation is connected to other metabolic pathways, including ethanol metabolism and oxidative stress responses.
Fatty acid oxidation is not an isolated process; it intersects with ethanol metabolism in the liver, where both pathways compete for NAD+ and produce acetyl-CoA. This interaction can lead to hepatic steatosis and altered redox balance. In cancer cells, myoglobin expression can suppress fatty acid oxidation and migration via heme-dependent oxidant production, suggesting that fatty acid oxidation is integrated with cell motility signaling. Nutritional interventions such as royal jelly plus coenzyme Q10 supplementation have been shown to improve high-intensity interval exercise performance via changes in plasmatic and salivary biomarkers of oxidative stress and muscle damage, indicating that systemic fatty acid oxidation capacity can be influenced by supplementation.
Key Genes Involved in GO:0019395 fatty acid oxidation
The following genes and proteins are experimentally linked to fatty acid oxidation or its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACADM | Medium-chain acyl-CoA dehydrogenase in mitochondrial beta-oxidation | Model for inherited fatty acid oxidation disorders |
| ACADVL | Very-long-chain acyl-CoA dehydrogenase | Target for peroxisomal and mitochondrial oxidation studies |
| CPT1A | Carnitine palmitoyltransferase 1A, rate-limiting for mitochondrial import | Regulation of fatty acid oxidation flux |
| CPT2 | Carnitine palmitoyltransferase 2, inner membrane transfer | Defects cause CPT II deficiency |
| HADHA | Trifunctional protein subunit, long-chain enoyl-CoA hydratase | Mitochondrial trifunctional protein deficiency |
| HADHB | Trifunctional protein subunit, 3-ketoacyl-CoA thiolase | Fatty acid oxidation disorder models |
| ETFA | Electron transfer flavoprotein alpha subunit | Electron transfer to respiratory chain |
| ETFB | Electron transfer flavoprotein beta subunit | Glutaric acidemia type II |
| ETFDH | Electron transfer flavoprotein dehydrogenase | Multiple acyl-CoA dehydrogenase deficiency |
| PPARA | Peroxisome proliferator-activated receptor alpha | Transcriptional regulation of fatty acid oxidation genes |
| PPARGC1A | PGC-1alpha, mitochondrial biogenesis coactivator | Regulation of oxidative capacity |
| MYG1 | Myoglobin, heme-containing oxygen carrier | Inhibits fatty acid oxidation in breast cancer cells |
| SLC25A20 | Carnitine-acylcarnitine translocase | Mitochondrial carnitine shuttle |
| ACOX1 | Peroxisomal acyl-CoA oxidase 1 | Peroxisomal fatty acid oxidation |
| ALDH2 | Aldehyde dehydrogenase 2 | Ethanol metabolism interaction with fatty acid oxidation |
| CYP2E1 | Cytochrome P450 2E1 | Ethanol-induced oxidative stress and fatty acid oxidation |
| GPX4 | Glutathione peroxidase 4 | Lipid peroxidation defense |
| NCOA4 | Nuclear receptor coactivator 4 | Ferritinophagy and iron-dependent oxidation |
How Is fatty acid oxidation Regulated?
Fatty acid oxidation is regulated at multiple levels, including transcriptional control by PPARA and PPARGC1A, post-translational modification of enzymes, and substrate availability. In the liver, ethanol metabolism alters the NADH/NAD+ ratio, which inhibits beta-oxidation and promotes steatosis. Copper availability modulates mitochondrial hydrogen peroxide emission during fatty acid oxidation, indicating that trace metal homeostasis can influence oxidative flux. Nutritional factors such as omega-3 fatty acids and coenzyme Q10 supplementation can also affect mitochondrial bioenergetics and oxidative stress markers [4,6]. Additionally, myoglobin can suppress fatty acid oxidation in breast cancer cells via heme-dependent oxidant production, representing a non-canonical regulatory mechanism.
fatty acid oxidation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACADM | Medium-chain acyl-CoA dehydrogenase deficiency | Knockout cell model in hepatocytes |
| CPT2 | CPT II deficiency and rhabdomyolysis | Point-mutation knock-in in myocytes |
| HADHA | Mitochondrial trifunctional protein deficiency | Knockout in fibroblasts |
| MYG1 | Breast cancer migration and fatty acid oxidation | Overexpression in breast cancer cell lines |
| ALDH2 | Alcoholic liver disease and ethanol metabolism | Knockout in hepatocytes |
Cardiovascular disease and atherosclerosis
Fatty acid oxidation products are detectable in human atherosclerotic plaque, where they may contribute to inflammation and plaque instability. LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants shows evidence of peroxidation, linking dietary fatty acids and smoking to oxidative modification of lipoproteins. These findings suggest that non-enzymatic fatty acid oxidation is a mechanistic contributor to cardiovascular pathology.
Cancer metabolism and metastasis
Myoglobin inhibits breast cancer cell fatty acid oxidation and migration via heme-dependent oxidant production and not fatty acid binding, revealing a novel role for heme chemistry in cancer cell metabolism. This suggests that fatty acid oxidation can be modulated by intracellular oxygen carriers and that targeting this pathway may influence metastatic potential.
Metabolic liver disease and ethanol interaction
Fatty acid oxidation interacts with ethanol metabolism in the liver, where both pathways compete for NAD+ and produce acetyl-CoA. This interaction can lead to hepatic steatosis and altered redox balance, making fatty acid oxidation a key consideration in alcoholic and non-alcoholic fatty liver disease.
Exercise-induced oxidative stress and muscle damage
Royal jelly plus coenzyme Q10 supplementation improves high-intensity interval exercise performance via changes in plasmatic and salivary biomarkers of oxidative stress and muscle damage in swimmers, indicating that fatty acid oxidation and related oxidative processes are relevant to exercise physiology. Omega-3 fatty acid intake also influences skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults.
From fatty acid oxidation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ACADM impair mitochondrial fatty acid oxidation? | ACADM knockout cell line |
| Does a specific point mutation in CPT2 alter carnitine shuttle activity? | CPT2 point-mutation knock-in |
| Can MYG1 overexpression inhibit fatty acid oxidation in cancer cells? | MYG1 overexpression in breast cancer cells |
| Does copper availability affect mitochondrial H2O2 emission during fatty acid oxidation? | Copper chelation or supplementation in cardiomyocytes |
| Does omega-3 supplementation alter skeletal muscle bioenergetics? | Primary myotubes treated with omega-3 fatty acids |
| Does ethanol exposure alter fatty acid oxidation flux? | Hepatocyte model with ethanol treatment |
How to Study the fatty acid oxidation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| High-resolution respirometry | Oxygen consumption during fatty acid oxidation | Mitochondrial function in knockout cells |
| Lipid peroxidation assays | Malondialdehyde, 4-HNE, lipid hydroperoxides | Oxidative stress in cardiovascular disease [7,8] |
| Stable isotope tracing | Flux of 13C-labeled fatty acids into TCA cycle | Metabolic pathway interactions |
| RNA-seq | Expression of fatty acid oxidation genes | Transcriptional regulation by PPARA/PPARGC1A |
| Proteomics | Protein abundance of oxidation enzymes | Mitochondrial bioenergetics in muscle |
| Seahorse XF assay | Extracellular acidification and oxygen consumption | Real-time fatty acid oxidation in live cells |
| Western blot | Protein levels of ACADM, CPT1A, etc. | Validation of knockout or overexpression |
| CRISPR library screening | Identification of genes required for fatty acid oxidation | Functional genomics of oxidative metabolism |
Respirometry and mitochondrial function assays
High-resolution respirometry can measure oxygen consumption rates in intact cells or isolated mitochondria during fatty acid oxidation. This method is useful for assessing the impact of gene knockouts or point mutations on oxidative capacity. Copper modulation of mitochondrial H2O2 emission during fatty acid oxidation has been studied using such approaches.
Lipid peroxidation and oxidative stress markers
Measurements of lipid hydroperoxides, malondialdehyde, and 4-hydroxynonenal can quantify non-enzymatic fatty acid oxidation. These markers have been used to detect oxidized fatty acid products in human atherosclerotic plaque and in LDL from hyperlipidemic smokers [7,8]. Salivary and plasmatic biomarkers of oxidative stress have also been used in exercise supplementation trials.
Metabolic flux analysis with stable isotopes
Stable isotope tracing using 13C-labeled fatty acids can track the flux of fatty acid oxidation into the TCA cycle and other metabolic pathways. This approach is valuable for distinguishing between mitochondrial and peroxisomal oxidation and for assessing the interaction between fatty acid oxidation and ethanol metabolism.
Transcriptional and proteomic profiling
RNA-seq and proteomics can identify changes in the expression of fatty acid oxidation genes such as PPARA, PPARGC1A, and ACADM. These methods are useful for understanding how nutritional or pharmacological interventions, such as omega-3 supplementation, affect the oxidative machinery.
How CRISPR Can Be Used to Study GO:0019395 fatty acid oxidation
Knockout
CRISPR knockout of genes such as ACADM, CPT1A, or HADHA can be used to abolish specific steps in fatty acid oxidation. These models are essential for determining whether a candidate gene is causally involved in oxidative flux and for studying compensatory pathways. Knockout cell lines can be subjected to respirometry and lipid peroxidation assays to quantify the impact on GO:0019395.
Point Mutation
Point mutations in fatty acid oxidation genes, such as those found in CPT2 deficiency, can be introduced using CRISPR base editing or homology-directed repair. These models allow researchers to study the functional consequences of specific clinical variants without confounding effects from complete gene loss. Point-mutation knock-in cell lines are valuable for drug screening and mechanistic studies.
Knock-in
Knock-in of tagged versions of fatty acid oxidation enzymes, such as ACADM-FLAG or CPT1A-GFP, enables live-cell imaging and affinity purification. These models help determine subcellular localization and protein interactions during fatty acid oxidation. Knock-in of disease-associated mutations can also recreate patient-specific phenotypes in vitro.
Overexpression
Overexpression of genes such as MYG1 or PPARGC1A can enhance or suppress fatty acid oxidation depending on the context. For example, MYG1 overexpression inhibits fatty acid oxidation in breast cancer cells via heme-dependent oxidant production. Overexpression models are useful for gain-of-function studies and for testing whether increased oxidative capacity protects against metabolic stress.
How EDITGENE Supports fatty acid oxidation Research
Researchers studying fatty acid oxidation-related genes often need to determine whether a candidate gene is causally involved in oxidative flux, redox balance, or disease phenotypes. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for fatty acid oxidation research.
Frequently Asked Questions About fatty acid oxidation
What is GO:0019395 fatty acid oxidation?
GO:0019395 is a Gene Ontology biological process term defined as the removal of one or more electrons from a fatty acid, with or without concomitant proton removal, by reaction with an electron-accepting substance, by addition of oxygen, or by removal of hydrogen.
What genes are involved in fatty acid oxidation?
Key genes include ACADM, CPT1A, CPT2, HADHA, HADHB, ETFA, ETFB, ETFDH, PPARA, PPARGC1A, ACOX1, and MYG1, among others [1,2,3,6].
How is fatty acid oxidation regulated in the liver?
It is regulated by redox state, ethanol metabolism, and transcriptional factors such as PPARA; ethanol alters NADH/NAD+ ratios and inhibits beta-oxidation.
Can myoglobin affect fatty acid oxidation in cancer?
Yes, myoglobin inhibits breast cancer cell fatty acid oxidation and migration via heme-dependent oxidant production and not fatty acid binding.
Does copper influence fatty acid oxidation?
Copper modulates heart mitochondrial H2O2 emission differently during fatty acid and pyruvate oxidation.
What supplements affect fatty acid oxidation during exercise?
Royal jelly plus coenzyme Q10 supplementation improves high-intensity interval exercise performance via changes in oxidative stress biomarkers.
Are omega-3 fatty acids linked to fatty acid oxidation in muscle?
Omega-3 fatty acid intake influences skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults.
What diseases are associated with fatty acid oxidation?
Cardiovascular disease, atherosclerosis, cancer metabolism, and metabolic liver disease are associated with altered fatty acid oxidation [1,2,7,8].
How can I study fatty acid oxidation in the lab?
Common methods include respirometry, lipid peroxidation assays, stable isotope tracing, RNA-seq, and CRISPR knockout models [1,3,6,7,8].
What CRISPR models are available for fatty acid oxidation research?
Knockout, point mutation, knock-in, and overexpression models can be generated for genes such as ACADM, CPT1A, and MYG1 [1,2].
Conclusion
GO:0019395 fatty acid oxidation is a central biological process that encompasses enzymatic and non-enzymatic electron removal from fatty acids. Its dysregulation is implicated in liver disease, cardiovascular pathology, cancer metabolism, and exercise-induced oxidative stress. Understanding the genes and regulatory mechanisms involved requires robust experimental models, and CRISPR-based approaches offer precise tools for dissecting causal relationships. EDITGENE provides end-to-end services to support fatty acid oxidation research with custom cell models and bioinformatics.
References
- 1. Lu Y et al.. 2024. Interaction between fatty acid oxidation and ethanol metabolism in liver.. Am J Physiol Gastrointest Liver Physiol 326(5):G483-G494 PMID: 38573193
- 2. Johnson AR et al.. 2024. Myoglobin inhibits breast cancer cell fatty acid oxidation and migration via heme-dependent oxidant production and not fatty acid binding.. Free Radic Biol Med 225:208-220 PMID: 39368517
- 3. Isei MO et al.. 2022. Copper modulates heart mitochondrial H(2)O(2) emission differently during fatty acid and pyruvate oxidation.. Comp Biochem Physiol C Toxicol Pharmacol 254:109267 PMID: 35026399
- 4. Ovchinnikov AN et al.. 2022. Royal jelly plus coenzyme Q10 supplementation improves high-intensity interval exercise performance via changes in plasmatic and salivary biomarkers of oxidative stress and muscle damage in swimmers: a randomized, double-blind, placebo-controlled pilot trial.. J Int Soc Sports Nutr 19(1):239-257 PMID: 35813842
- 6. Lalia AZ et al.. 2017. Influence of omega-3 fatty acids on skeletal muscle protein metabolism and mitochondrial bioenergetics in older adults.. Aging (Albany NY) 9(4):1096-1129 PMID: 28379838
- 7. Brude IR et al.. 1997. Peroxidation of LDL from combined-hyperlipidemic male smokers supplied with omega-3 fatty acids and antioxidants.. Arterioscler Thromb Vasc Biol 17(11):2576-88 PMID: 9409230
- 8. Waddington E et al.. 2001. Identification and quantitation of unique fatty acid oxidation products in human atherosclerotic plaque using high-performance liquid chromatography.. Anal Biochem 292(2):234-44 PMID: 11355856
